The global Indoor Farming Market size is estimated to reach USD 122.3 billion by 2030, exhibiting a CAGR of 13.5% from 2022 to 2030, according to the new report conducted by Grand View Research, Inc. The increasing demand for food owing to the rising population is expected to drive the growth. Factors such as declining water supply, urbanization, and climate change have contributed to the loss of arable land. This, in turn, is driving demand for indoor farms to produce food. In addition, challenges, such as rising global temperature and extreme weather conditions, act as a barrier to the traditional farming technique. The European Environment Agency (EEA) has carried out several initiatives to build vertical farms to overcome these challenges and produce food in an eco-friendly way.
Indoor farming increases the crop yield and reduces the farming impact on the environment by reducing the distance traveled in the supply chain. It reduces the need for the land space required to grow plants compared to traditional farming methods by using growing shelves mounted vertically. Rising consumer awareness regarding the consumption of healthy and fresh food is anticipated to positively influence the market for indoor farming during the forecast period. Furthermore, the use of technology, such as LED indoor farming, to create nature-like conditions will help farmers meet the expected demand for food supply in the near future. Europe dominated the market in 2021 and is anticipated to remain dominant over the forecast period, owing to the continuous adoption of advanced technologies such as LED lighting, and controlled environment agriculture. Asia Pacific is expected to exhibit the fastest CAGR from 2022 to 2030, owing to the increasing indoor farms in countries such as China and Japan. Increasing adoption of greenhouses and vertical farms is expected to support regional growth. In addition, the rising demand for pesticide-free, fresh vegetables and fruits is expected to fuel the regional market growth. Related Press Release@ Indoor Farming Market Report Indoor Farming Market Report Highlights
0 Comments
The global Insulin Delivery Devices Market size is expected to reach USD 27.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2022 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.
Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry. The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector. Related Press Release@ Insulin Delivery Devices Market Report Insulin Delivery Devices Market Report Highlights
The global Anatomic Pathology Market size is expected to reach USD 34.66 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.08% from 2021 to 2028. The advent of technology in the instruments and the protocols used during the anatomic pathological procedures is anticipated to increase the adoption rate of advanced anatomic pathological instruments.
Market players are collaborating for the refurbishment of pathology products by the incorporation of innovative disease diagnostic models. In April 2021, Leica Biosystems collaborated with Paige, an AI-based diagnostics company, for expanded access to computational pathology products for translational and clinical research. Under this partnership, Paige’s AI-enabled research software and Leica Biosystems’ digital pathology platform were combined. This, in turn, accelerates investments in the up-gradation of pathological equipment. Pathology-training programs offered to pathologist trainees by public and private entities drive the market. For instance, the Accreditation Council for Graduate Medical Education accredited residency programs for anatomic pathology provide education and training to individuals via numerous teaching conferences. The drug discovery and development application segment are expected to witness the fastest growth over the forecast period due to the shifting paradigm from conventional medicine to personalized medicine. This is primarily due to the growing reliance on discoveries of putative biomarkers for the development of personalized therapies. Ongoing pathology training programs to ensure that the pathology residents are aware of the developments taking place in the field of personalized medicine have also accelerated the market growth. North America held the largest revenue share in 2020 owing to a large number of funding programs by public agencies and the presence of key players. Asia Pacific is expected to witness the fastest growth due to the presence of multiple associations that are engaged in conducting pathology training programs. Key players are undertaking various strategic initiatives such as mergers & acquisitions and new product development to maintain their market presence. For instance, in May 2021, CellCarta acquired Reveal Biosciences, an AI-based pathology firm. This acquisition is aimed at expanding CellCarta’s offerings in AI-enabled multi-omic data analysis services and applications. Related Press Release@ Anatomic Pathology Market Report Anatomic Pathology Market Report Highlights
U.S. Biopharmaceutical 3PL Market: Future Trends, Revenue Growth & Leading Players, Forecast To 20284/12/2022 The U.S. Biopharmaceutical Third Party Logistics Market size is expected to reach USD 62.3 billion by 2028, at a CAGR 7.1% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for novel biologics and the need to manage those is boosting the market growth. Moreover, the rising demand for temperature-controlled logistic services to transport biologics in various regions and the growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the market growth.
The COVID-19 pandemic has had a major impact on global logistics to some extent due to diminished air freight capacity and reduced workforce at warehouses and airports. The decisions of local authorities to shut down the logistic infrastructure, enforce movement restriction, or put in place additional requirements to suppress transmission of the virus have also impacted the logistic services. This has significantly hindered many supply operations. The future seems lucrative for the market with the retraction of government regulations related to transportation and shelter-in-place mandates. A sudden surge in the demand for cold chain logistics was observed during the pandemic. Growth in the manufacture and distribution of the COVID-19 vaccine is expected throughout 2021. For instance, in March 2021, FedEx Express started shipping the COVID19 vaccine for McKesson Corp. to centers all across the U.S. The company has already shipped millions of COVID-19 vaccines since mid-December 2020. Related Press Release@ U.S. Biopharmaceutical Third Party Logistics Market Report U.S. Biopharmaceutical 3PL Market Report Highlights
The global Medical Simulation Market size is expected to reach a value of USD 5.48 billion by 2028. The market is expected to expand at a CAGR of 16.3% from 2021 to 2028. With recent technological advancements, the use of new medical devices and advanced procedures, such as enhanced mechanical ventilation devices, cardiac assist devices, and intra-cardiac echocardiography technology, is increasing; which drives the need for advanced training solutions, such as simulation, for customer training and internal product development. Certification and regulatory agencies are strictly recommending that physicians and clinicians be trained before the adoption of new, disruptive technologies. Although hands-on learning with real patients cannot be replaced, simulation training offers safe learning conditions. Students and medical residents making mistakes in this phase is an important part of the learning process, as in simulation training patients are not put at risk.
Education Management Solutions, LLC- a company dealing in medical simulation learning management technology-released workflows that were COVID-19 contingency ready for healthcare education. CAE Healthcare responded to the pandemic by helping with a complimentary webinar, SCE, and outreach toolkit to assist educators. Such factors boosted the demand for medical simulation services during the pandemic. The market is very competitive. The most notable market participants are CAE, Laerdal Medical, 3D Systems, Simulab Corporation, Limbs & Things Ltd, Mentice AB, Simulaids, Gaumard Scientific Company, Surgical Science Sweden AB, Kyoto Kagaku Co., Ltd and account for a considerable share owing to their product offerings to the market. Market leaders are involved in the establishment of extensive distribution systems as well as in mergers and acquisitions to capture a larger share of the market. For instance, in January 2021, Gaumard Scientific Company revealed its ultrasound system and pediatric emergency scenario modules for Pediatric HAL. Related Press Release@ Medical Simulation Market Report Medical Simulation Market Report Highlights
The global Endoscopy Procedures Estimates Market number is expected to reach 249.5 million procedures by 2030 and is expected to expand at a CAGR of 1.3% over the forecast period, according to a new report by Grand View Research, Inc. Growing prevalence of functional gastrointestinal disorders is one of the major factors for the high adoption of minimally invasive endoscopic procedures. For example, according to the data published by the endoscopy center of the gastroenterology associates of Pensacola, each year, about 62 million Americans are diagnosed with a digestive disorder. Similarly, in 2020, another report published in the Gastroenterology journal stated that over 40% of people in the world have functional gastrointestinal disorders.
Moreover, the increasing prevalence of gastrointestinal cancers is also expected to accelerate the adoption of endoscopy procedures all over the globe. Moreover, technological advancements in endoscopy devices further accelerate the adoption of this procedure to diagnose and treat several gastrointestinal disorders. The advancement of endoscopic devices to view intra-abdominal organs using video endoscopy and the integration of computer software with endoscopic devices also supports the adoption of endoscopic procedures. In addition, the growing preference for minimally invasive surgeries owing to lesser post-surgery complications, shorter hospital stays, and a quick recovery period increases the adoption of endoscopic surgeries. Based on application, the gastroscopy segment dominated the market in 2021. This high share is attributed mainly to the increasing number of upper gastrointestinal endoscopy procedures performed across the globe. Gastroscopic surgeries are performed to help physicians diagnose the stomach, esophagus, and upper intestine. In addition, increasing recommendations by the physicians to perform gastroscopy to identify complications, such as gastroesophageal blockage, inflammation, and gastroesophageal reflux disease, are also expected to be responsible for the high share of the segment. For example, the data published in the journal Scientific Reports stated that, globally, over 1.03 billion people suffer from gastroesophageal reflux disease. On the other hand, the COVID-19 pandemic had drastically impacted the adoption of endoscopic procedures in 2020. The reduction in overall surgery volumes coupled with long-term shutdowns and lockdowns substantially decreased the number of endoscopic surgeries. Furthermore, increasing coronavirus infections among health workers also hindered the market growth in 2020. However, significant growth of minimally invasive endoscopic surgeries is expected with the situation moving towards normalcy over the forecast years. Related Press Release@ Endoscopy Procedures Estimates Market Report Endoscopy Procedures Estimates Market Report Highlights
The global Cardiovascular And Soft Tissue Repair Patches Market size is expected to reach USD 7.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. The rapidly rising prevalence of congenital heart diseases, such as Atrial Septal Defect (ASD)and the ventricular septal defect is expected to drive the demand for the patches. In addition, increasing implementation of patches in medical procedures and growing sports injuries is expected to support the development and growth of the market over the forthcoming years. As per studies, ASD is the second most common type of congenital heart disease and the incidence rate across the global population is recorded to be 56 per 100,000 live births.
One of the key driving market forces is the rapidly rising prevalence of cardiovascular diseases. Changing lifestyles, growing obesity levels, adoption of unhealthy lifestyle habits, increasing alcohol consumption and smoking, and growing geriatric population are driving the incidence of cardiac disorders. As per World Health Organization estimates, cardiovascular diseases account for the largest share of 32% or 17.9 million deaths annually. As per the Centers for Disease Control and Prevention estimates, approximately 695,000 deaths in the U.S. are due to underlying cardiac diseases. Coronary heart diseases are recorded in the majority of cardiac disorder-related deaths. As per the Centers for Disease Control and Prevention estimates, coronary heart diseases accounted for 360,900 deaths in the U.S. in 2019. Another key driving force supporting growth is the rising prevalence of hernias such as inguinal hernia, umbilical hernia, congenital diaphragmatic hernia, ventral hernia, and others. Some of the risk factors associated with hernias are heavy weight lifting, abdominal surgery, ascites, constipation, and chronic cough which increases the pressure on intra-abdominal regions resulting in abdominal hernias. Inguinal hernias are the commonest abdominal hernias and the incidence rate of inguinal hernia repairs in the U.K. is 10 per 100,000 individuals and in the U.S. are 28 per 100,000 individuals. Congenital diaphragmatic hernia is caused due to genetic factors and residual embryological channel defects. The abovementioned factors are driving the demand for patches in therapeutic procedures and wound care management. Related Press Release@ Cardiovascular And Soft Tissue Repair Patches Market Report Cardiovascular And Soft Tissue Repair Patches Market Report Highlights
The global Orthopedic Regenerative Surgical Products Market size is anticipated to reach USD 5.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 3.9% from 2022 to 2030. The key factors driving the market growth include the rising geriatric population, orthopedic procedures, research activities, and technological advancements. Osteoarthritis, for instance, has been identified as the leading cause of chronic disability in the geriatric population over the age of 70. The World Health Organization (WHO) has also designated osteoarthritis as a ‘priority disease’ promoting R&D for therapies to treat osteoarthritis and its associated symptoms.
The growth of the market was restrained during the COVID-19 pandemic due to deferred elective surgeries, low volume of patient flow for chronic conditions in clinics and hospitals, decreased sales and marketing activities, quarantine and lockdown protocols, and low demand. Vericel Corporation, for example, reported the adverse impact of COVID-19 on its business and operations during 2020. The company registered cancellations of scheduled MACI procedures; its key product used in the repair of cartilage damage of the knee. In addition, there was a slowdown in new orders. Anika Therapeutics reported challenges in patient enrollment for its clinical trials due to the pandemic, which negatively impacted the company’s revenue and operating results. However, both companies expect recovery financial performance as elective surgeries resumes to pre-COVID numbers. According to the Centers for Disease Control and Prevention (CDC), about 26% (or 78 million) the U.S. adults are estimated to suffer from arthritis by 2040. The prevalence increases with age and is found to be more common in women. Obesity has been identified as another risk factor contributing to orthopedic conditions. The prevalence of obesity in the U.S. was estimated at 42.4% from 2017 to 2018 by the CDC. The increasing prevalence of orthopedic diseases, obesity, and geriatric population is expected to fuel market growth. Orthopedic regenerative surgical products find application in different conditions of varying severity from joint pain, gout, articular defects, fibromyalgia, and osteoarthritis, to trauma and joint replacement, this is expected to contribute to market growth. Market players are also involved in research and development activities to launch new regenerative solutions for treatment or pain relief from orthopedic conditions. Amniox Medical, Inc. for instance, received FDA clearance to proceed with a dosing study using TTAX03- its Investigational New Drug (IND) comprising cryopreserved amniotic membrane and umbilical cord, to treat facet joint osteoarthritis pain in March 2021. Zimmer Biomet on the other hand offers an extensive portfolio of allografts and synthetic orthopedic regenerative products such as the PrimaGen Advanced allograft, InterGro DBM, and PlatFORM bioresorbable bone graft substitute. Related Press Release@ Orthopedic Regenerative Surgical Products Market Report Orthopedic Regenerative Surgical Products Market Report Highlights
The global Remote Patient Monitoring System Market size is expected to reach USD 6.7 billion by 2030, according to a new report by Grand View Research Inc. It is projected to register a CAGR of 20.2% from 2022 to 2030. COVID-19 pandemic has a significant impact on the remote patient monitoring system. The main drivers for this market are the increasing geriatric population, cost-effective treatment, and the rising prevalence of chronic conditions. The breakout of Covid-19 has propelled the demand for remote patient monitoring devices and services as healthcare facilities were burdened with Covid-19 infected patients. Key players like Smiths Medical reported that the demand of their home monitoring devices substantially increased during the pandemic.
The amalgamation of telehealth with remote patient monitoring services is expected to further boost market growth. Asia Pacific is also projected to be a key revenue generator in the coming years. The region is backed by developing countries such as China, South Korea, and Thailand which are witnessing an increase in the number of chronic diseases owing to lifestyle changes. Cardiovascular disease is among the leading cause of death in these countries. The remote patient monitoring system is expected to play a key role in the early detection and timely management of these diseases. Related Press Release@ Remote Patient Monitoring System Market Report Remote Patient Monitoring System Market Report Highlights
The global Skincare Devices Market size is expected to reach USD 34.3 billion By 2030, registering a CAGR of 11.9%, according to a new report by Grand View Research, Inc., An increasing number of skin-related disorders such as cancer and assorted disorders are likely to increase the adoption rate of these devices.
Rising use of home-care products and growing medical spa treatments are some of the key trends stimulating market growth. Some of the key factors that are driving growth are technological advancements, growing appearance consciousness, and rising disposable income. Growing awareness regarding the benefits of skin rejuvenation amongst patients, rising demand for aesthetics, and increasing incidence of skin disorders are among the primary growth stimulants. Syneron Medical, a U.S.-based company, is one of the biggest players in the skin rejuvenation market. Its product is known as VelaSmooth which has been approved by the U.S. FDA. The market is projected to witness significant growth over the forecast period, owing to the rising prevalence of skin diseases. Technological advancements, extremely effective devices, and increasing acceptance of these devices as they are non-invasive, are some of the factors escalating the growth of the market. Furthermore, surging demand for processes such as liposuction, body contouring, skin rejuvenation, and tightening is anticipated to accelerate the growth of the market. However, equipment cost and competitive pricing are limiting the market from realizing its utmost potential. Related Press Release@ Skincare Devices Market Report Skincare Devices Market Report Highlights
|
Archives
October 2023
|